What is ALK mutation in lung cancer?
ALK is short for anaplastic lymphoma kinase. It’s a mutation in the DNA of your lung cells that happens when two genes become fused, or stuck together. When you have this mutation, your lung cells make too many copies of themselves. These cells are cancerous and can spread to other parts of your body.
Can ALK lung cancer be cured?
Stage IV is the most advanced form; meaning the disease has spread to distant parts of your body, such as your bones or brain. Stage IV is very hard to cure, if not impossible, for ALK-positive lung cancer at this time.
How is ALK-positive lung cancer treated?
Crizotinib, an ALK inhibitor, is effective in treating advanced ALK-positive NSCLC, and the US Food and Drug Administration approved it for treating ALK-positive NSCLC in 2011. Several mechanisms of acquired resistance to crizotinib have recently been reported.
What is ALK test for?
ALK is a short name for the anaplastic lymphoma receptor tyrosine kinase gene. This test detects specific rearrangements in the ALK gene in cancer cells and tissue. The presence of these changes makes it more likely that a person with non-small cell lung cancer will respond to a targeted drug therapy.
What does ALK mean in cancer?
ALK stands for anaplastic lymphoma kinase. It was originally described in lymphoma, but most ALK-positive cancers are in non-small cell lung cancer. The ALK gene is in your body when you are an embryo.
What is ALK medicine?
ALK inhibitors are anti-cancer drugs that act on tumours with variations of anaplastic lymphoma kinase (ALK) such as an EML4-ALK translocation. They fall under the category of tyrosine kinase inhibitors, which work by inhibiting proteins involved in the abnormal growth of tumour cells.
What is the meaning of ALK?
ALK means “Alcohol.”
What is ALK rearrangement and how does it cause cancer?
For some people, it gets turned back on and fuses (joins) with another gene. This gene change is called an ALK fusion or ALK rearrangement and can cause cancer. When ALK fuses or joins with another gene and causes lung cancer, a patient is said to be ALK-positive. ALK can fuse with different genes. The most common one is called EML4.
Are ALK rearrangements in non-small cell lung cancer (NSCLC) possible?
Transforming rearrangements of the ALK (anaplastic lymphoma kinase) gene have recently been described in non-small cell lung cancer (NSCLC).
What is alkalk-positive lung cancer?
ALK-positive lung cancer is caused by a rearrangement of the ALK gene, but we do not know why this rearrangement happens. Lung Cancer is the most common cancer worldwide as well as the leading cause of cancer-related deaths.
Does ALK fusion work in non‐small‐cell lung cancer?
Since then, ALK has been associated with other types of cancers, including non‐small‐cell lung cancer (NSCLC). More than 19 different ALK fusion partners have been discovered in NSCLC, including EML4, KIF5B, KLC1, and TPR. Most of these ALK fusions in NSCLC patients respond well to the ALK inhibitor, crizotinib.
